AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 17 filers reported holding AMBRX BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,611,000 | -59.2% | 1,491,832 | 0.0% | 0.07% | -55.3% |
| Q2 2022 | $3,953,000 | -35.7% | 1,491,832 | 0.0% | 0.15% | -20.2% |
| Q1 2022 | $6,146,000 | -35.7% | 1,491,832 | +41.0% | 0.19% | +1.6% |
| Q4 2021 | $9,551,000 | -58.3% | 1,057,735 | -9.6% | 0.18% | -46.1% |
| Q2 2021 | $22,923,000 | – | 1,169,529 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 1,932,591 | $2,087,000 | 0.22% |
| Cormorant Asset Management, LP | 2,336,389 | $2,523,000 | 0.18% |
| Artal Group S.A. | 2,152,291 | $2,324,000 | 0.10% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,491,832 | $1,611,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,027,291 | $2,189,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 42 | $0 | 0.00% |
| Renaissance Technologies | 64,000 | $69,000 | 0.00% |
| ROYAL BANK OF CANADA | 42,453 | $46,000 | 0.00% |
| UBS Group AG | 7,967 | $9,000 | 0.00% |
| FMR LLC | 3,588,467 | $3,876,000 | 0.00% |